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1  | INTRODUC TION
Since	 the	 invention	of	 the	 radioimmunoassay	 in	 the	1950s,	 immu‐
noassays	have	become	the	standard	methods	 for	 the	detection	of	
many	clinically	important	proteins	and	peptides.	Without	immuno‐
assays,	 the	diagnosing	many	medical	 conditions	 and	being	 able	 to	
monitor	these	medical	conditions	at	follow‐up	visits	would	be	seri‐
ously	affected.	However,	despite	several	years	of	advancements	in	













The	 suspicion	 of	 immunoassay	 interference	 could	 be	 raised	
when	test	results	are	discordant	with	the	clinical	presentation	of	the	










The	 presence	 of	 discrepant	 results	 after	 various	 sample	 treat‐
ments	 is	 another	 hallmark	 of	 interference.	 Serial	 dilutions	 are	




and	 false‐positive	 results	 are	 likely	 if	 heterogeneous	 analytes	 are	
being	 investigated.10	 Blocking	 of	 interfering	 antibodies	 with	 non‐
specific	 immunoglobulins	 (Igs)	 is	another	method,	but	the	blocking	
agents	have	to	be	adapted	to	the	specific	immunoassay	to	maximize	
the	chance	of	success.	An	alternative	approach	to	tackle	 immuno‐
assay	 interference	 is	 to	deplete	 the	samples	of	 Igs	by	 treating	 the	
samples	with	a	precipitant,	such	as	polyethylene	glycol	 (PEG).	PEG	
lowers	the	solubility	of	Igs	and	has	been	reported	to	precipitate	both	
serum	 IgG	 and	 IgM	efficiently.11,12	A	 sample	 treatment	 procedure	
with	PEG	is	quickly	performed,	and	feasible	to	implement	into	nor‐
mal	laboratory	routines.	The	present	study	aimed	to	evaluate	if	anti‐









until	 analysis.	 All	 samples	were	 thawed	 at	 room	 temperature	 (RT)	
and	 thoroughly	 vortexed	 before	 analysis.	 Exclusion	 criteria	 were	
clearly	visible	signs	of	hemolysis,	bilirubinemia,	or	lipemia.
Control	 sera	were	 collected	 from	 the	 routine	 laboratory	 anal‐
ysis	of	progesterone	at	 the	University	Animal	Hospital	 in	Uppsala,	
Sweden,	 and	 from	 a	 sampling	 of	 staff‐owned	 dogs.	 Serum	 was	
frozen	 and	 stored	 at	 −20°C	 for	 up	 to	 3	months	 until	 analysis.	 All	
samples	were	 thawed	at	RT	and	 thoroughly	vortexed	before	anal‐
ysis.	 Inclusion	criteria	for	control	dogs	were	a	negative	anti‐mouse	




The	 study	 was	 approved	 by	 the	 Uppsala	 Ethical	 Committee	 of	
Animal	 Experimentation	 (C	 136/13).	 In	 accordance	 with	 Swedish	








ing	hormone	 (TSH),	and	canine	TT4	 (the	 last	 three	 from	Siemens	
Healthcare	 Diagnostics).	 The	 aim	 was	 to	 include	 immunoassays	

















2.4 | Selection of samples and prioritization of  
the immunoassay order
To	 evaluate	 if	 anti‐mouse	 antibodies	 are	 a	 source	 of	 erroneous	
results	 in	 the	 AMH	 assay,	 neutered	 dogs	 were	 used,	 seven	 with	
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anti‐mouse	antibodies	detected	using	a	species‐independent	assay1 































for	 30	minutes,	 followed	 by	 centrifugation	 for	 5	minutes	 at	 9600g 
in	 a	 Heraeus	 Fresco	 17/21	microcentrifuge	 (Thermo	 Fisher,	 Hemel	













Chi‐square	test	was	then	performed	for	H0:p1 = p2 = p3,	and	so	on.	








TA B L E  1  Assays	tested	on	dogs	with	anti‐mouse	antibodies.	
Descriptive	data	of	sampled	dogs	and	immunoassay	allocation	of	
samples	investigated	for	interference
Breed Age (y) Sex Assays tested
Boxer 6 F AMH,	TT4,	TSH,	
progesterone
Rottweiler 10 F AMH,	TT4,	TSH,	
progesterone
Poodle 12 M AMH,	TT4,	TSH
Miniature	Schnauzer 8 M AMH,	TT4,	TSH
Bernese	Mountain	Dog 7 MN AMH,	TT4,	TSH
Finnish	hound 3 F AMH,	TT4,	
progesterone
Schipperke 5 F AMH,	TSH,	
progesterone
Jack	Russell	Terrier 4 F AMH,	TT4,	
progesterone
Mixed‐breed	dog 1 M AMH,	TT4
German	Shepherd	Dog 4 mo M AMH,	TT4
Shetland	Sheepdog 11 mo M AMH,	TT4
Irish	Terrier 7 M AMH,	TT4
Shetland	Sheepdog 9 F AMH,	TT4




Bearded	Collie 7 M AMH,	TT4
Jagdterrier 9 M AMH,	TSH
Lagotto	Romagnoloa 5 M AMH,	TSH
Bernese	Mountain	Dog 8 FN AMH,	TT4,	TSH
Miniature	Schnauzer 10 FN AMH,	TSH
German	Spaniel 7 F AMH,	progesterone
Papillon 3 MN AMH
Bernese	Mountain	Dog 5 FN AMH
Golden	Retriever 11 M AMH
Mixed‐breed	dog 1 F AMH
Mixed‐breed	dog 9 F AMH
Chihuahua 13 MN AMH











were	 four	 intact	 males,	 five	 neutered	males,	 14	 intact	 females,	 and	
two	neutered	females.	The	median	age	was	4	years,	IQR	2.5‐	5	years.	







3.3 | Effect of anti‐mouse antibodies on the 
result of the AMH assay
Serum	 from	 none	 of	 the	 seven	 neutered	 control	 dogs,	 but	 serum	
from	 two	 of	 seven	 neutered	 dogs	 with	 anti‐mouse	 antibodies	
yielded	detectable	AMH	concentrations.	These	 two	dogs	also	had	





patient	was	 referred	 to	 the	University	Animal	Hospital	 in	Uppsala	
with	 acute	 gastrointestinal	 signs.	 A	 blood	 test	 revealed	 hypogly‐
cemia	 (2.5	mmol/L,	RI	3.8‐5.8).	After	3	days	of	 intensive	care,	 the	
patient	was	released	from	the	hospital,	free	from	clinical	signs,	and	
with	normalized	glucose	concentrations.
The	 initial	 AMH	 testing	 on	 serum	 1	 yielded	 a	 result	 of	
14.49	 pmol/L.	 Interference	 testing	was	 performed	with	 concentra‐
















aggregated	 MAK33	 and	 0.5	 mg/mL	 MAK33	 +	 0.5	 mg/mL	 I5381.	


















Canine	TSH	(µg/L) 0.08 4.4 20
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Heat‐aggregated	MAK33	(0.5	mg/mL)	decreased	the	result	by	54%	(to	
2.64	pmol/L)	 and	0.5	mg/mL	 I5381	decreased	 the	adult	by	35%	 (to	
3.71	pmol/L).	The	AMH	concentrations	were	below	the	detection	limit	
when	the	serum	was	treated	with	PEG.
3.4 | Assay screening with PEG












The	 probability	 of	 getting	 a	 discrepant	 result	 after	 PEG	 treat‐
ment	differed	significantly	depending	on	whether	AMH,	TSH,	TT4,	
or	progesterone	was	analyzed.	This	was	true	for	samples	with	anti‐





ies	 did	 not	 have	 discrepant	 results	 in	 any	 of	 the	 immunoassays.	
Conversely,	discrepant	results	were	found	in	at	least	one	of	the	im‐
munoassays	for	all	25	serum	samples	without	anti‐mouse	antibodies.
For	 assay‐specific	 effects	 of	 PEG	 on	 samples	with	 anti‐mouse	
antibodies	and	controls	(See	Figures	3‐6).
4  | DISCUSSION
The	present	 study	evaluated	 if	 anti‐mouse	antibodies,	detected	 in	
a	 species‐independent	 immunoassay,	 were	 a	 source	 of	 erroneous	
F I G U R E  2  Effects	of	polyethylene	glycol	(PEG)	treatment	and	antibody	blocking	on	samples	with	erroneous	anti‐Müllerian	hormone	
(AMH)	results.	For	blocking,	different	concentrations	of	two	mouse	antibodies	(MAK33	and	I5381)	were	used.	The	antibodies	were	also	used	
in	combination	with	0.5	mg/mL	of	each
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tered	 dogs	 previously	 screened	 for	 interference,	 these	 two	 dogs	
also	had	the	strongest	reactivity	with	anti‐mouse	IgG.	Immunoassay	
manufacturers	add	neutralizing	 Igs	to	their	sample	 incubation	buf‐





explained	 by	 the	 absence	 of	 Sertoli	 cells	 in	 males,	 and	 of	 gran‐
ulosa	 cells	 in	 females,	which	are	 the	only	 known	 sources	of	AMH	
in	mammals6,16,17	The	AMH	assay	is	used	for	several	 indications	 in	
dogs,	 including	 diagnosing	 the	 presence	 of	 gonads,2,4‐6,14	 gonadal	
tumors,18,19	and	predicting	 litter	size.20	The	 interferences	found	 in	
the	present	study	might	not	be	a	big	problem	for	diagnosing	tumors,	
as	 granulosa	 and	 Sertoli	 cell	 tumors	 generally	 increase	AMH	con‐
centrations	by	several	magnitudes,18,19	but	they	could	be	misleading	
when	 the	 neutering	 status	 of	 a	 dog	 is	 unknown,	 such	 as	 in	 cases	
of	 suspected	 ovarian	 remnants,	 cryptorchidism,	 or	 for	 stray	 and	
TA B L E  3  A	summary	of	the	polyethylene	glycol	(PEG)	effects.	The	effects	on	hormone	measurements	after	PEG	treatment	for	samples	
with	(mouse:	pos)	and	without	(mouse:	neg)	anti‐mouse	antibodies
AMH TSH TT4 Progesterone Overall
Number	of	discrepancies Mouse:	pos 14/14	(100%) 5/10	(50%) 6/14	(43%) 0/6	(0%) 25/44	(57%)
Mouse:	neg 17/17	(100%) 8/10	(80%) 15/18	(83%) 1/11	(9%) 41/56	(73%)
Median	percentage	of	meas‐
urement	decrease
Mouse:	pos 75% 26% 23% 0*  29%




F I G U R E  3  The	effects	of	polyethylene	glycol	(PEG)	treatment	on	canine	thyroxine	(TT4)	measurements.	Healthy	control	samples	negative	
for	anti‐mouse	IgG	are	to	the	left.	Patient	samples	positive	for	anti‐mouse	IgG	are	to	the	right
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surrendered	dogs	admitted	to	animal	shelters	with	unknown	med‐








effect	 of	 interference.	 Blocking	 with	 0.5	 mg/mL	 purified	 mouse	
polyclonal	 IgG	had	 little	 to	no	effect,	 but	0.5	mg/mL	heat‐aggre‐



































F I G U R E  4  The	effects	of	polyethylene	glycol	(PEG)	treatment	on	canine	thyroid‐stimulating	hormone	(TSH)	measurements.	Healthy	
control	samples	negative	for	anti‐mouse	IgG	are	to	the	left.	Patient	samples	positive	for	anti‐mouse	IgG	are	to	the	right





study	 also	 reported	 stable	 values	 for	 thyroxine	 (TT4).






of	 the	 analyses	 yielded	 discrepant	 results.	 Further	 progesterone	
assay	interference	studies	could	be	warranted	if	the	exact	concen‐
trations	are	used	to	determine	the	optimal	time	for	mating.	Before	
investigating	 interference	 with	 PEG,	 laboratories	 should	 perform	
in‐house	 tests	 for	 specific	 analytes	 on	 control	 sera	 to	 figure	 out	
how	big	a	difference	is	normally	expected	after	PEG	treatment.
An	 extensive	 evaluation	 of	 methods	 for	 removal	 of	 hetero‐
philic	antibodies	in	canine	plasma	was	performed	by	Solter	et	al.25 
Although	the	favored	protocol	was	relatively	 lengthy	and	 involved	
reagents	 that	may	not	be	standard	 in	 laboratories,	 the	preliminary	
results	 were	 encouraging.	 The	 methods	 attempted	 by	 the	 Solter	
group	could	be	preferable	to	those	attempted	by	our	group	 in	the	
present	study,	especially	 if	 the	method	 is	only	 to	be	performed	 in	
a	few	selected	cases.	We	also	saw	promising	results	when	treating	
sera	 that	 had	 erroneous	 AMH	 results	 with	 heat‐aggregated	 IgG.	
However,	this	method	has	to	be	evaluated	more	thoroughly	before	
it	can	be	recommended	to	be	used	for	dog	samples.	This	method	is	
also	 less	convenient	 to	 implement	 in	practice,	because	 immunoas‐






assay	are	 likely	 to	be	superior	 to	commercial	heterophilic	blocking	
reagents	(HBR),	which	contain	multispecies	Igs	that	by	chance	could	




Although	 PEG	 treatment	 was	 not	 useful	 in	 detecting	 canine	
antibody	interference,	 interference	caused	by	anti‐mouse	antibod‐




F I G U R E  5  The	effects	of	polyethylene	glycol	(PEG)	treatment	on	progesterone	measurements.	Healthy	control	samples	negative	for	
anti‐mouse	IgG	are	to	the	left.	Patient	samples	positive	for	anti‐mouse	IgG	are	to	the	right
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mouse	 antibodies.	 The	 detected	 antibodies	 could	 cause	 interfer‐
ence	 in	 the	other	 assays	 to	 a	 lower	extent	because	most	of	 them	










When	immunoassay	 interference	 is	discussed,	 it	 is	often	pre‐
sumed	that	measurements	are	falsely	increased	(positive	interfer‐
ence).	 However,	 negative	 antibody	 interference	 is	 also	 possible,	
but	less	commonly	observed.	With	the	selection	of	immunoassays	




in	 an	 assay	 that	 combines	 a	monoclonal	mouse	 antibody	on	 the	

























F I G U R E  6  The	effects	of	polyethylene	glycol	(PEG)	treatment	on	anti‐Müllerian	hormone	(AMH)	measurements.	Healthy	control	samples	
were	negative	for	anti‐mouse	IgG	are	to	the	left.	Patient	samples	positive	for	anti‐mouse	IgG	are	to	the	right
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